Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jun 08, 2023 3:05pm
87 Views
Post# 35487044

RE:Avenanthramide scale-up to commercial-scale almost complete

RE:Avenanthramide scale-up to commercial-scale almost completeMore than one in every 10 adults in the US are diabetic.

"Based on our results, we have confirmed for the first time that the glucose uptake is indeed inhibited by the presence of avenanthramides, suggesting the possibility of incorporating avenanthramides in foods to enhance postprandial glucose response, and ultimately improve the management of diabetes. Therefore, future research could consider utilizing this evidence in the development of diabetic-friendly functional foods or nutraceuticals containing avenanthramides." 
The inhibition of intestinal glucose absorption by oat-derived avenanthramides - PubMed (nih.gov)

-----
3. Helps Diabetics

Research shows that, in moderation, oats can be a healthy and helpful food for diabetics and others struggling with blood sugar issues. The aim of a 2015 scientific review was to figure out if oats intake is beneficial for diabetic patients. The researchers looked at 14 controlled trials and two uncontrolled observational studies, and the findings are quite impressive.

 

Compared with the controls, “oats intake significantly reduced” the concentrations of A1c and fasting blood glucose as well as total cholesterol and LDL cholesterol. The conclusion of the review is that oats intake can benefit both blood sugar control and lipid profiles in type 2 diabetics, making it a great addition to any diabetic diet plan. (6)

--------
 

<< Previous
Bullboard Posts
Next >>